Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Cell ; 184(12): 3281-3298.e22, 2021 06 10.
Article in English | MEDLINE | ID: mdl-34019796

ABSTRACT

Organs are composed of diverse cell types that traverse transient states during organogenesis. To interrogate this diversity during human development, we generate a single-cell transcriptome atlas from multiple developing endodermal organs of the respiratory and gastrointestinal tract. We illuminate cell states, transcription factors, and organ-specific epithelial stem cell and mesenchyme interactions across lineages. We implement the atlas as a high-dimensional search space to benchmark human pluripotent stem cell (hPSC)-derived intestinal organoids (HIOs) under multiple culture conditions. We show that HIOs recapitulate reference cell states and use HIOs to reconstruct the molecular dynamics of intestinal epithelium and mesenchyme emergence. We show that the mesenchyme-derived niche cue NRG1 enhances intestinal stem cell maturation in vitro and that the homeobox transcription factor CDX2 is required for regionalization of intestinal epithelium and mesenchyme in humans. This work combines cell atlases and organoid technologies to understand how human organ development is orchestrated.


Subject(s)
Anatomy, Artistic , Atlases as Topic , Embryonic Development , Endoderm/embryology , Models, Biological , Organoids/embryology , CDX2 Transcription Factor/metabolism , Cell Line , Epidermal Growth Factor/pharmacology , Epithelial Cells/cytology , Female , Gastrulation , Gene Deletion , Gene Expression Regulation, Developmental/drug effects , Humans , Intestines/embryology , Male , Mesoderm/embryology , Middle Aged , Neuregulin-1/metabolism , Organ Specificity , Pluripotent Stem Cells/cytology
2.
Nat Rev Genet ; 24(10): 687-711, 2023 10.
Article in English | MEDLINE | ID: mdl-36737647

ABSTRACT

Our ancestors acquired morphological, cognitive and metabolic modifications that enabled humans to colonize diverse habitats, develop extraordinary technologies and reshape the biosphere. Understanding the genetic, developmental and molecular bases for these changes will provide insights into how we became human. Connecting human-specific genetic changes to species differences has been challenging owing to an abundance of low-effect size genetic changes, limited descriptions of phenotypic differences across development at the level of cell types and lack of experimental models. Emerging approaches for single-cell sequencing, genetic manipulation and stem cell culture now support descriptive and functional studies in defined cell types with a human or ape genetic background. In this Review, we describe how the sequencing of genomes from modern and archaic hominins, great apes and other primates is revealing human-specific genetic changes and how new molecular and cellular approaches - including cell atlases and organoids - are enabling exploration of the candidate causal factors that underlie human-specific traits.


Subject(s)
Hominidae , Animals , Humans , Hominidae/genetics , Organoids , Biological Evolution , Evolution, Molecular
3.
Nat Commun ; 8(1): 2126, 2017 12 19.
Article in English | MEDLINE | ID: mdl-29259247

ABSTRACT

Juvenile myelomonocytic leukemia (JMML) is an aggressive myeloproliferative disorder of early childhood characterized by mutations activating RAS signaling. Established clinical and genetic markers fail to fully recapitulate the clinical and biological heterogeneity of this disease. Here we report DNA methylome analysis and mutation profiling of 167 JMML samples. We identify three JMML subgroups with unique molecular and clinical characteristics. The high methylation group (HM) is characterized by somatic PTPN11 mutations and poor clinical outcome. The low methylation group is enriched for somatic NRAS and CBL mutations, as well as for Noonan patients, and has a good prognosis. The intermediate methylation group (IM) shows enrichment for monosomy 7 and somatic KRAS mutations. Hypermethylation is associated with repressed chromatin, genes regulated by RAS signaling, frequent co-occurrence of RAS pathway mutations and upregulation of DNMT1 and DNMT3B, suggesting a link between activation of the DNA methylation machinery and mutational patterns in JMML.


Subject(s)
DNA Methylation , Leukemia, Myelomonocytic, Juvenile/genetics , Noonan Syndrome/genetics , Protein Tyrosine Phosphatase, Non-Receptor Type 11/genetics , Proto-Oncogene Proteins p21(ras)/genetics , Signal Transduction/genetics , Antineoplastic Agents/therapeutic use , Biopsy , Child , Child, Preschool , Chromatin/genetics , Chromatin/metabolism , DNA (Cytosine-5-)-Methyltransferase 1/metabolism , DNA (Cytosine-5-)-Methyltransferases/metabolism , DNA Mutational Analysis , Epigenomics , Female , Gene Expression Regulation, Leukemic , Hematopoietic Stem Cell Transplantation , Humans , Infant , Leukemia, Myelomonocytic, Juvenile/mortality , Leukemia, Myelomonocytic, Juvenile/pathology , Leukemia, Myelomonocytic, Juvenile/therapy , Male , Mutation , Noonan Syndrome/pathology , Prognosis , Prospective Studies , Protein Tyrosine Phosphatase, Non-Receptor Type 11/metabolism , Proto-Oncogene Proteins c-cbl , Proto-Oncogene Proteins p21(ras)/metabolism , Up-Regulation , DNA Methyltransferase 3B
SELECTION OF CITATIONS
SEARCH DETAIL